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Engineered C–N Lyase: Enantioselective Synthesis of Chiral Synthons
for Artificial Dipeptide Sweeteners
Jielin Zhang, Eleonora Grandi, Haigen Fu, Thangavelu Saravanan, Laura Bothof,
Pieter G. Tepper, Andy-Mark W. H. Thunnissen, and Gerrit J. Poelarends*
Abstract: Aspartic acid derivatives with branched N-alkyl or
N-arylalkyl substituents are valuable precursors to artificial
dipeptide sweeteners such as neotame and advantame. The
development of a biocatalyst to synthesize these compounds in
a single asymmetric step is an as yet unmet challenge. Reported
here is an enantioselective biocatalytic synthesis of various
difficult N-substituted aspartic acids, including N-(3,3-dime-
thylbutyl)-l-aspartic acid and N-[3-(3-hydroxy-4-methoxyphe-
nyl)propyl]-l-aspartic acid, precursors to neotame and advan-
tame, respectively, using an engineered variant of ethylenedi-
amine-N,N’-disuccinic acid (EDDS) lyase from Chelativorans
sp. BNC1. This engineered C–N lyase (mutant D290M/
Y320M) displayed a remarkable 1140-fold increase in activity
for the selective hydroamination of fumarate compared to that
of the wild-type enzyme. These results present new opportu-
nities to develop practical multienzymatic processes for the
more sustainable and step-economic synthesis of an important
class of food additives.
Introduction
Artificial low-calorie sweeteners are used as sugar re-
placements in the food industry, with the benefits of control-
ling energy intake and blood glucose levels, improving dental
health, and other health concerns related to sugar over-
consumption.[1–6] The dipeptide aspartame, which is about
200-fold sweeter than sucrose (Scheme 1A), is one of the
most widely used artificial sweeteners with a substantial
production volume each year.[7] The derivatization of aspar-
tame with branched N-alkyl- or N-arylalkyl groups generates
even sweeter compounds, such as the more recently approved
food additives neotame and advantame (Scheme 1A).[6,8–10]
Notably, neotame is 7000–13000 times sweeter than sucrose,
while advantame is about 20000 times sweeter than sucrose.
A common synthetic method for neotame and advantame
production is the reductive N-alkylation of aspartame with
the corresponding aldehyde in the presence of hydrogen using
a palladium (Pd/C) or platinum (Pt/C) hydrogenation catalyst
(Scheme 1B, Method 1).[10–14] An alternative strategy for
neotame production involves N-(3,3-dimethylbutyl)-l-aspart-
ic acid [l-3a] as a precursor, which is linked to l-phenyl-
alanine methyl ester by amide-bond coupling (Scheme 1B,
Method 2).[15–17] This precursor is chemically synthesized by
reductive N-alkylation of l-aspartic acid (or its ester deriv-
ative) using transition-metal catalysts (Pd/C or Pt/C). Sim-
ilarly, N-[3-(3-hydroxy-4-methoxyphenyl)propyl]-l-aspartic
acid [l-3 f] could be chemically prepared by reductive N-
alkylation of l-aspartic acid and serve as precursor to
advantame. However, the development of a biocatalyst for
enantioselective synthesis of these difficult N-substituted
aspartic acids l-3a and l-3 f, in a single asymmetric step, is
to date an unmet challenge.
Here we report the engineering of an effective C–N lyase,
based on ethylenediamine-N,N’-disuccinic acid (EDDS) lyase
from Chelativorans sp. BNC1,[18–20] for the enantioselective
syntheses of l-3a and l-3 f, precursors to neotame and
advantame, respectively, as well as related chiral synthons for
aspartame-based sweeteners starting from the simple non-
chiral compound fumaric acid (1, Scheme 1C). This newly
engineered C–N lyase shows a 1140-fold increase in activity
for the selective hydroamination of fumarate compared to
that of the wild-type enzyme, opening up new opportunities to
design practical multienzymatic processes for the more
sustainable and step-economic synthesis of an important class
of food additives.
Results and Discussion
Our group has previously reported that an engineered
variant of 3-methylaspartate ammonia lyase (MAL-Q73A)
accepts various amines, including butylamine (2c, Table 1),
for enantioselective hydroamination of fumarate (1).[21,22]
Structurally, the amines 2b and 2a have, respectively, one
and two extra methyl group(s) at C3 compared with 2c. This
difference prompted us to start our investigations by testing
the branched amines 2a and 2b as unnatural substrates in the
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MAL-Q73A-catalyzed hydroamination of 1. Although 2b
was accepted by MAL-Q73A for slow hydroamination of
1 (see Figure S1 in the Supporting Information), yielding
optically pure l-3b (ee > 99%), 2a was unfortunately not
accepted as a substrate by MAL-Q73A. This observation
suggests that the bulky tert-butyl group of 2a prevents
productive binding in the enzyme active site, making 2a
a challenging substrate for C–N lyases.
We continued our investigations by testing whether
EDDS lyase, which has previously been shown to possess an
exceptionally broad amine scope,[18–20] can accept 2a as an
unnatural substrate in the hydroamination of 1. Pleasingly,
EDDS lyase accepted 2a for addition to 1, giving rise to 3a.
Under optimized reaction conditions, excellent conversion
(92% after 7 days) and good yield (67%) of isolated 3a were
achieved using a 0.15 mol% biocatalyst loading (Table 1; see
Figure S2). The enzymatic product 3a was identified as the
desired l enantiomer with greater than 99% ee. The amines
2b and 2c were also readily converted by EDDS lyase to
afford the respective optically pure products l-3b and l-3c
(> 99% ee) with 93–95% conversion and in 66–74% yield
upon isolation. Interestingly, the bulky arylalkylamines 2d–f
were also accepted as substrates by EDDS lyase, yielding the
respective products l-3d–f. High conversions (82–97% after
7 days) and excellent enantioselectivities (> 99% ee) were
observed.
Although EDDS lyase is the first identified biocatalyst to
synthesize l-3a in a single asymmetric step, its catalytic
activity for this transformation is quite low, resulting in
a rather long reaction time of 7 days when using a 0.15 mol%
biocatalyst loading. Therefore, a structure-based protein
engineering strategy was applied to enhance this hydro-
amination activity of EDDS lyase. On the basis of the
structure of EDDS lyase in complex with its natural substrate
Scheme 1. A) Structures of the low-calorie artificial dipeptide sweeteners aspartame, neotame, and advantame. B) Current synthesis methods for
neotame and advantame involve metal-catalyzed reductive N-alkylation. C) Biocatalytic asymmetric synthesis of N-substituted aspartic acids 3 as
precursors for potential multienzymatic synthesis of neotame and advantame.
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(S,S)-EDDS (Figure 1),[18] two residues (Asp290 and Tyr320)
were chosen for site-saturation mutagenesis (SSM) because of
their presumed roles in positioning of the amine substrate for
addition to fumarate. Specifically, residue Asp290 forms
a water-mediated hydrogen bond with the internal amino
group connected to the distal succinyl moiety of (S,S)-EDDS,
which appears to be an important interaction for binding and
positioning of ethylenediamine and other diamine substrates
(but not for monoamines such as 2a) for addition to fumarate.
The bulky aromatic ring of Tyr320 may further preclude
optimal positioning of 2a.
Accordingly, two focused libraries were constructed by
randomizing the positions Asp290 and Tyr320, yielding
libraries D290X and Y320X. The libraries were transformed
into Escherichia coli cells and screened by evaluating about
100 transformants of each library. Initially, we evaluated
mutants in the D290X library by monitoring the depletion of
1 in a spectrophotometric kinetic assay in multiwell plates
using cell free extracts (CFEs). However, this screening was
unsuccessful because 1 was converted at a similar rate by all
CFEs, including a CFE prepared from E. coli cells not
producing EDDS lyase (see Figure S3). We assumed that this
relatively high background consumption of 1 was caused by
indigenous fumarase (FumC) activity present in the E. coli
CFE, resulting in the undesired hydration of 1 to give l-malic
acid, which outcompeted the slower EDDS lyase mediated
hydroamination of 1.[23, 24] Considering that the removal of
fumarase by enzyme purification from CFEs is quite labori-
ous and not suitable for library screening, we tested whether
the addition of fumarase inhibitors (d-malate, citrate, and
glycerol) could suppress FumC-dependent hydration of 1.
While d-malate and citrate did not show sufficient inhibition
(data not shown), the addition of glycerol (45%, v/v) to the
screening assay effectively inhibited FumC-catalyzed hydra-
tion of 1 (see Figures S4A and S5). It has been reported that
glycerol inhibits FumC by affecting a conformational change,
which appears to be the rate-limiting step, based on its
viscogenic effect.[25] Importantly, control experiments dem-
onstrated that the activity of EDDS lyase, measured by the
addition of ethylene diamine to 1, was not inhibited by
glycerol (see Figure S4B). Based on these optimizations, 45%
(v/v) glycerol was included in the screening assay as additive
Table 1: Enantioselective synthesis of neotame and advantame precursors, as well as related compounds, using EDDS lyase or its engineered variant
D290M/Y320M as a biocatalyst.
Entry Amine Product WT[a] D290M/Y320M[b] ee[d]
Conv. (yield)[c] [%] t [days] Conv. (yield)[c] [%] t [h] [%]
1 2a 3a 92 (67) 7 96 (83) 2.5[e] >99
2 2b 3b 93 (74) 7 93 (81) 2.5[e] >99
3 2c 3c 95 (66) 7 92 (68) 2.5[e] >99
4 2d 3d 97 (45) 7 96 (49) 6 >99
5 2e 3e 93 (40) 7 90 (40) 6 >99
6 2 f 3 f 82 (34) 7 82 (34) 6 >99
[a] Reaction conditions: fumaric acid (1, 10 mm), amine (2a–f, 50 or 100 mm), and EDDS lyase WT (0.05 or 0.15 mol% based on fumaric acid) in
NaH2PO4/NaOH buffer (pH 8.5) at room temperature. [b] Reaction conditions: fumaric acid (1, 10 mm), amine (2a–f, 50 or 100 mm), glycerol (45%,
v/v), and EDDS lyase D290M/Y320M (0.05 mol% based on fumaric acid) in NaH2PO4/NaOH buffer (pH 8.5) at room temperature. [c] Conversion
was determined by 1H NMR spectroscopy. Yield of isolated product determined after ion-exchange chromatography. [d] The ee value was determined
by high-performance liquid chromatography on a chiral stationary phase using chemically synthesized authentic standards. [e] The apparent kcat/Km
values (using 5 mm 1) were estimated to be 5.1 (2c), 12.8 (2b), and 14.5m@1s@1 (2a).
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to suppress the FumC-catalyzed hydration of 1, enabling
hydroamination activity screening of mutant libraries using
CFEs instead of purified proteins.
Using this optimized assay, screening of the D290X and
Y320X libraries resulted in the identification of five mutants
(D290L, D290V, Y320M, Y320V and Y320L) with signifi-
cantly improved activity. These mutant enzymes were purified
to homogeneity and assayed for their ability to catalyze the
addition of 2a to 1 to yield 3a. The best mutant from the
D290X library (D290L) showed a 55-fold enhanced activity,
while the best mutant from the Y320X library (Y320M)
displayed a remarkable 620-fold increase in activity compared
to that of the wild-type enzyme (Figure 2; see Table S2).
To further improve the catalytic activity of EDDS lyase,
we used an iterative saturation mutagenesis (ISM) strategy,
using the best four hits from the single-site libraries as
templates and randomizing the other respective position.
Accordingly, the libraries D290L/Y320X, Y320M/D290X,
Y320V/D290X, and Y320L/D290X were constructed. The
screening of these libraries resulted in the identification of
four double mutants, D290M/Y320M, D290H/Y320M,
D290L/Y320M, and D290M/Y320V, which showed activity
improvement over the best single mutant Y320M. Based on
assays using purified enzymes, the mutant D290M/Y320M
was shown to be the best mutant enzyme, with a striking 1140-
fold increase in activity compared to that of the wild-type
enzyme (Figure 2; see Table S2). Notably, the mutant enzyme
D290L/Y320M, in which the two best single mutations at each
position are combined, displayed a lower activity compared to
that of mutant D290M/Y320M (Figure 2), illustrating the
importance of using an ISM approach to identify the best
mutant.
To understand how the mutations cause the large increase
in activity we determined crystal structures of the EDDS
lyase variant D290M/Y320M. Crystal structures were ob-
tained with either fumarate or formate occupying the active
site (see Table S3 and Figure S6), like previously shown for
the wild-type enzyme.[18] Similar as in the wild-type structure,
fumarate is bound tightly in the active site of the mutant
through interactions with its two carboxylate groups, while its
Cb atom faces the hydroxy oxygen atom of Ser280, the
catalytic base, at a distance of 3 c. A second fumarate is
bound somewhat away from the active site, in a region which
in the wild-type structure is responsible for binding the distal
succinate group of (S,S)-EDDS. The formate-bound mutant
structure contains three formate ions, two of which occupy
positions in the active site where the carboxylate groups of
fumarate bind, further denoting the integrity of the active site.
A detailed comparison of the mutant and wild-type structures
revealed no significant differences in overall protein struc-
ture, nor in the conformations of the active site residues
responsible for binding and activating fumarate prior to the
amine addition. Mutations D290M and Y320M are located at
opposite sides of the presumed amine binding pocket, and the
main structural consequences of the amino-acid substitutions
are a slight reshaping of the pocket and a significant increase
of its hydrophobicity (Figure 3A,B). Further insights were
obtained from docking 3a in the EDDS lyase wild-type and
mutant crystal structures (efforts to obtain crystal structures
with bound 3a were unsuccessful). The modeling results show
that while residues Asp290 and Tyr320 in the wild-type
structure form unfavorable polar–apolar contacts with the
3,3-dimethylbutyl moiety of 3a, residues Met290 and Met320
in the mutant structure are able to form favorable apolar–
apolar contacts (Figure 3C,D). The increased hydrophobicity
of the pocket resulting from the D290M and Y320M
mutations thus leads to improved binding interactions with
the apolar 3,3-dimethylbutyl moiety of 3a, suggesting that the
Figure 1. A) Structures of natural substrate (S,S)-EDDS and target compound (S)-3a. B) A close-up of the active site of EDDS lyase with bound
(S,S)-EDDS (PDB: 6G3H). The bound (S,S)-EDDS (green) and side chains of residues forming the amine binding pocket are shown using stick
representation. The two target residues for mutagenesis, Asp290 and Tyr320, are shown in yellow.
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large increase in activity of mutant enzyme D290M/Y320M is
a consequence of much stronger, and possibly more produc-
tive, binding of 2a.
Importantly, we observed that the activity of the mutant
enzyme D290M/Y320M for the addition of 2a (100 mm) to
1 (5 mm) was affected by glycerol. The enzymatic activity
decreased significantly (ca. 2.5-fold) when the glycerol
concentration in the reaction mixture was reduced from
45% to 30% (v/v) and became almost undetectable when the
glycerol concentration was lowered to less than or equal to
20% (see Figure S7). This decrease in enzyme activity upon
lowering the glycerol concentration was accompanied by
slight protein precipitation. Since the D290M/Y320M mutant
was observed to be stable and fully active after several hours
of incubation in buffer (without amine substrate) at room
temperature, it appears that in the presence of high concen-
trations of 2a (100 mm), the D290M/Y320M mutant is not
stable and loses activity. In the reaction mixture with 100 mm
2a, the D290M/Y320M mutant was stabilized by glycerol
(45%, v/v), which is a routinely used stabilizing agent for
proteins.[26, 27] Note that the addition of 45% (v/v) glycerol did
not effect the hydroamination activity of the wild-type
enzyme under the same reaction conditions (see Figure S8).
Interestingly, this implies that glycerol played dual roles in
mutant library screening. It served both as fumarase inhibitor
and as protein stabilizer. The presence of 45% (v/v) glycerol
during library screening was thus essential for the identifica-
tion of the D290M/Y320M mutant, suggesting that the
incorporation of cosolvents in screening assays is an appealing
strategy to identify mutants with the desired activity, but
having reduced stability, in enzyme evolution. Our results
provide support for the notion that protein stability is a major
constraint in enzyme evolution, and buffering mechanisms
such as the inclusion of stabilizing cosolvents are key in
relieving this constraint.[28]
Having generated an EDDS lyase variant with strongly
improved catalytic activity (mutant D290M/Y320M), we
tested its performance as biocatalyst for the synthesis of our
target 3a. With a 0.05 mol% biocatalyst loading, starting
substrates 1 and 2a were readily converted to afford the
optically pure l-3a (> 99% ee) with 96% conversion after
only 2.5 hours (instead of 7 days as observed for the same
transformation with the wild-type enzyme) and in 83% yield
upon isolation (entry 1 in Table 1; see Figure S9). To further
demonstrate the synthetic usefulness of this newly engineered
C–N lyase, 2b–f were tested as substrates in the hydro-
amination of 1. The enzymatic reactions proceeded smoothly
to afford enantiomerically pure products l-3b–f (> 99% ee)
with 82–96% conversion (after a few hours rather than
7 days) and in 34–81% yield (Table 1, entries 2–6; see Fig-
ure S10). These amino-acid products (except l-3d) are key
building blocks for N-functionalized aspartame derivatives
that were reported to be much sweeter than sucrose.[8]
Notably, l-3 f is a chiral precursor for the synthesis of
advantame (Scheme 1), which, like neotame, has already
been approved for application in food products.
Conclusion
In conclusion, we have successfully engineered a C–N
lyase for efficient asymmetric addition of challenging amines
to fumarate to yield optically pure N-(3,3-dimethylbutyl)-l-
aspartic acid and N-[3-(3-hydroxy-4-methoxyphenyl)propyl]-
l-aspartic acid, which are important precursors to neotame
and advantame, respectively. Interestingly, the presence of
glycerol during laboratory evolution was essential for the
identification of this improved C–N lyase, suggesting that the
inclusion of stabilizing cosolvents is an appealing strategy to
reduce the constraining effects of protein stability during
enzyme evolution. The newly developed biocatalytic method-
ology offers a useful alternative route to important chiral
synthons for artificial dipeptide sweeteners. The engineered
C–N lyase nicely supplements the toolbox of biocatalysts for
production of unnatural amino acids, and opens up new
opportunities to develop an entirely enzymatic route for the
straightforward synthesis of valuable aspartame-based sweet-
Figure 2. Engineering of EDDS lyase for efficient synthesis of 3a.
A) Activity improvement of EDDS lyase variants over wild type.
Reaction conditions: 1 (5 mm), 2a (100 mm), purified enzyme
(0.15 mol% based on fumaric acid), glycerol (45%, v/v) in NaH2PO4/
NaOH buffer (pH 8.5) at RT. Reactions were monitored by following
the depletion of 1 by UV spectroscopy at 270 nm. Reactions were
performed in triplicate (see Table S2 for details). B) Reaction progress
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eners, starting from the simple nonchiral dicarboxylic acid
1 (Scheme 1C). Although the engineered EDDS lyase variant
D290M/Y320M exhibits a respectable specific activity of
1.74 Umg@1 for the addition of 2a to 1, ongoing enzyme
engineering work in our group is focused on further improv-
ing its stability (in the absence of glycerol) and catalytic
efficiency (in terms of kcat/Km) for this reaction. As such, this
work sets the stage for further development of practical
multienzymatic processes for the more sustainable and step-
economic synthesis of an important class of food additives.
Experimental Section
Experimental Details : All experimental details can be found in
the Supporting Information.
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